Hinge Health, Inc. (NYSE:Hnge), a leading digital physical therapy startup, estimated its long -awaited IPO at $ 32 per share on Wednesday, at the top of its planned range, raising around 273 million dollars by selling 8.52 million shares. The company will start to negotiate itself on the New York Stock Exchange under the symbol of the Ticker “HNGE”.
A patient who consults his medical diagnosis on a digital health care ecosystem.
The company was founded in 2014 and offers software-oriented solutions to treat musculoskeletal injuries, chronic pain and rehabilitation after remote surgery. Despite a sharp decline compared to its private evaluation of $ 6.2 billion in 2021, the IPO appreciated the company at around 2.6 billion dollars.
The startup reported a strong financial dynamic, with a turnover in the first quarter which amounts to 50% over one year over the other at 123.8 million dollars and to display a net income of $ 17.1 million, overthrowing a net loss of 26.5 million dollars compared to the previous year. The CEO of the co-founders Daniel Perez and the executive president Gabriel Mecklenburg have a personal experience of physical rehabilitation, leading their mission.
This IPO marks an important event for the digital health sector, which has experienced very few public offers since 2021 in the challenges of the post-camura market. With more than a billion dollars raised from the best investors, especially Global And Sleeve managementHinge Health, Inc. (NYSE: HGEN) The beginnings are closely monitored as a bell tower for the resumption of the sector.
“We have many decades of work in advance,” noted Perez, inviting investors to join the trip.
While we recognize the potential for HNGE growth, our conviction lies in the conviction that certain AI actions are more promising to provide higher yields and have a limited risk of decline. If you are looking for a more promising ia stock than HNGE and which has a 100x increase potential, consult our report on this subject Stock ai the cheapest.
Read then: 10 best cancer actions in which invest in long -term gains And 10 The most occurred shares to buy according to the billionaires.
Disclosure: None.